USD 200 million low-interest, five-year term loan commitment from Sumitomo Dainippon Pharma to further support planned commercialization of relugolix across […]
First Patient Receives New Sacral Neuromodulation Device Implant at Cleveland ClinicDUBLIN, Aug. 05, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the […]